Thrombosis Research Group
Our Team
Physicians/Scientists
Senior Scientists: Dr. Phil Wells; Dr. Marc Rodger
Associate Scientist: Dr. Marc Carrier
Clinical Investigators: Dr. Melissa Forgie; Dr. Dimitrios Scarvelis; Dr. Carol Gonsalves; Dr. Cathy Code; Dr. Alan Karovitch.
Fellows: Thrombosis Fellows are physicians with specialist training who spend between 1 and 3 years in Ottawa receiving additional training to become experts in venous thrombosis. Research fellows also receive education in research methods (clinical epidemiology) and actively participate in the design and conduct of clinical research related to thrombotic disease.
More information about the Thrombosis Fellowship Program
Research Team Members
We have an expanding team composed of individuals from a variety of backgrounds. Research staff members fall within four general categories.
Management and Administrative
Anne Marie Clement is the Thrombosis Program Manager
amclement@ohri.ca
Phone: 613 798-5555 ext. 19841
Cathy McSheffery is the Program Coordinator
cmcsheffery@ohri.ca
Phone: 613 798-5555 ext. 19324
Clinical Research Coordinators
Many of the Thrombosis Research Coordinators are registered nurses; however, they come from a variety of clinical backgrounds. These coordinators are responsible for the day-to-day operation of the program’s research and are the main contact for patients who are enrolled in our clinical trials and observational studies.
Multicentre Research Coordinators
These coordinators generally do not have direct contact with patients enrolled in our research studies. Rather, they oversee the smooth operation of large projects that are being conducted at multiple Canadian or International sites.
Laboratory Technicians
Two full-time laboratory technicians work in the Ottawa Thrombosis Genetics Research Laboratory performing genetic and laboratory analyses and maintaining a bank of blood and DNA samples.
Collaborators
The VECTOR (VEnous thromboembolic Clinical Trials ORganization) Group consists of thrombosis experts who collaborate on clinical research related to venous thromboembolic disease. Executive members, Drs. Phil Wells, Marc Rodger and Marc Carrier are based in Ottawa, Dr. Mike Kovacs is in London, Dr. Susan Kahn is in Montreal, and Dr. David Anderson is in Halifax. VECTOR has been very successful at diverse research endeavours including clinical trials, population-based studies, meta-analyses, observational research, economic analysis, and genetic studies. This multicentre research partnership provides the advantages of sharing knowledge and expertise and allowing for study recruitment at multiple sites. The VECTOR investigators have also established collaborative research relationships with other investigators from various fields.
